Smith & Nephew Regulatory News (SN.)

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc ordinary shares of USD 0.20 each

Identification code

ISIN: GB0009223206

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2024 final dividend payment on 28 May 2025.

Date of Transaction

2025 - 05 - 28

Place of Transaction

London Stock Exchange (XLON)

Name

(Position)

Director / PDMR

Price (£)

Volume

Aggregated information

Helen Barraclough

(Group General Counsel and Company Secretary)

PDMR

10.65669

803.57057

N/A Single Transaction

Craig Gaffin

(President, Global Orthopaedics)

PDMR

10.65669

331.91224

N/A Single Transaction

Paul Connolly

(President, Global Operations)

PDMR

10.65669

701.28312

N/A Single Transaction

Phil Cowdy

Chief Corporate Development & Corporate Affairs Officer

PDMR

10.65669

250.51541

N/A Single Transaction

Mizanu Kebede

(Chief Quality & Regulatory Affairs Officer)

PDMR

10.65669

553.43002

N/A Single Transaction

Deepak Nath

(Chief Executive Officer)

Director

10.65669

3,457.19103

N/A Single Transaction

Alison Parkes

(Chief Compliance Officer)

PDMR

10.65669

93.4531

N/A Single Transaction

Scott Schaffner

(President, Sports Medicine)

PDMR

10.65669

1,327.82169

N/A Single Transaction

Rohit Kashyap

(President, Advanced Wound Management and Global Commercial Operations)

PDMR

10.65669

332.8502

N/A Single Transaction

Elga Lohler

(Chief HR Officer)

PDMR

10.65669

411.65422

N/A Single Transaction